Liguo Wang
Liguo Wang
Mayo Clinic (Minnesota)
Verified email at - Homepage
Cited by
Cited by
RSeQC: quality control of RNA-seq experiments
L Wang, S Wang, W Li
Bioinformatics 28 (16), 2184-2185, 2012
CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model
L Wang, HJ Park, S Dasari, S Wang, JP Kocher, W Li
Nucleic acids research 41 (6), e74-e74, 2013
CrossMap: a versatile tool for coordinate conversion between genome assemblies
H Zhao, Z Sun, J Wang, H Huang, JP Kocher, L Wang
Bioinformatics 30 (7), 1006-1007, 2014
Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing
K Kannan, L Wang, J Wang, MM Ittmann, W Li, L Yen
Proceedings of the National Academy of Sciences 108 (22), 9172-9177, 2011
The Drosophila melanogaster transcriptome by paired-end RNA sequencing
B Daines, H Wang, L Wang, Y Li, Y Han, D Emmert, W Gelbart, X Wang, ...
Genome research 21 (2), 315-324, 2011
In vivo Atoh1 targetome reveals how a proneural transcription factor regulates cerebellar development
TJ Klisch, Y Xi, A Flora, L Wang, W Li, HY Zoghbi
Proceedings of the National Academy of Sciences 108 (8), 3288-3293, 2011
LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
D Wang, L Ding, L Wang, Y Zhao, Z Sun, RJ Karnes, J Zhang, H Huang
Oncotarget 6 (38), 41045, 2015
Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer
AG Sowalsky, Z Xia, L Wang, H Zhao, S Chen, GJ Bubley, SP Balk, W Li
Molecular Cancer Research 13 (1), 98-106, 2015
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
P Zhang, D Wang, Y Zhao, S Ren, K Gao, Z Ye, S Wang, CW Pan, Y Zhu, ...
Nature medicine 23 (9), 1055, 2017
BRCA1 is a negative modulator of the PRC2 complex
L Wang, X Zeng, S Chen, L Ding, J Zhong, JC Zhao, L Wang, A Sarver, ...
The EMBO journal 32 (11), 1584-1597, 2013
Truncated ERG oncoproteins from TMPRSS2-ERG fusions are resistant to SPOP-mediated proteasome degradation
J An, S Ren, SJ Murphy, S Dalangood, C Chang, X Pang, Y Cui, L Wang, ...
Molecular cell 59 (6), 904-916, 2015
Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer
C Zhang, L Wang, D Wu, H Chen, Z Chen, JM Thomas-Ahner, DL Zynger, ...
Cancer research 71 (21), 6738-6748, 2011
Measure transcript integrity using RNA-seq data
L Wang, J Nie, H Sicotte, Y Li, JE Eckel-Passow, S Dasari, PT Vedell, ...
BMC Bioinformatics 17, 1, 2016
Androgen receptor variant AR-V9 is coexpressed with AR-V7 in prostate cancer metastases and predicts abiraterone resistance
M Kohli, Y Ho, DW Hillman, JL Van Etten, C Henzler, R Yang, JM Sperger, ...
Clinical Cancer Research 23 (16), 4704-4715, 2017
Proteomic profiling of rice embryos from a hybrid rice cultivar and its parental lines
W Wang, B Meng, X Ge, S Song, Y Yang, X Yu, L Wang, S Hu, S Liu, J Yu
Proteomics 8 (22), 4808-4821, 2008
Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression
S Ren, GH Wei, D Liu, L Wang, Y Hou, S Zhu, L Peng, Q Zhang, Y Cheng, ...
European urology 73 (3), 322-339, 2018
MACE: model based analysis of ChIP-exo
L Wang, J Chen, C Wang, L Uusküla-Reimand, K Chen, A Medina-Rivera, ...
Nucleic acids research 42 (20), e156-e156, 2014
Global characterization of transcriptional impact of the SRC-3 coregulator
RB Lanz, Y Bulynko, A Malovannaya, P Labhart, L Wang, W Li, J Qin, ...
Molecular endocrinology 24 (4), 859-872, 2010
AKT‐phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1‐MAPK interaction
CW Pan, X Jin, Y Zhao, Y Pan, J Yang, RJ Karnes, J Zhang, L Wang, ...
The EMBO journal 36 (8), 995-1010, 2017
Histone modifications and chromatin organization in prostate cancer
Z Chen, L Wang, Q Wang, W Li
Epigenomics 2 (4), 551-560, 2010
The system can't perform the operation now. Try again later.
Articles 1–20